FTC SHIFTS FOCUS TO GENDER-AFFIRMING CARE

The FTC's new hires and investigative priorities suggest a concentrated effort to scrutinize gender-affirming treatments for children. The agency appears to be examining both the medical practices themselves and advocacy surrounding the treatments. The focus marks a notable shift in federal regulatory attention, as the FTC typically concentrates on consumer protection and competition issues. The investigation could potentially impact healthcare providers, pharmaceutical companies, and organizations that support transgender youth care. Gender-affirming care for minors remains medically and politically contested. Medical organizations including the American Medical Association support age-appropriate treatments, while some state legislatures have restricted such care. The FTC's involvement signals the federal government is now actively investigating the sector. Details on specific investigations and their scope remain limited. The timing coincides with broader political debates over transgender youth healthcare policy across federal and state levels.